NASDAQ · MRM
MEDIROM Healthcare Technologies Inc. American Depositary Share financials
$0.6849+5.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $52.8M | $48.4M | $53.0M | $47.0M | $31.4M |
| Gross profit | $14.3M | $11.1M | $14.5M | $12.3M | $4.0M |
| Gross margin | 27.1% | 23.0% | 27.4% | 26.2% | 12.8% |
| Operating income | -$115.1K | -$2.8M | $739.6K | -$4.1M | -$7.0M |
| Net income | $945.7K | $818.3K | $1.1M | -$8.6M | -$5.1M |
| Net margin | 1.8% | 1.7% | 2.1% | −18.3% | −16.1% |
| Diluted EPS | $0.18 | $0.16 | $0.21 | $-1.76 | $-1.26 |
| EBITDA | $1.9M | -$985.5K | $2.1M | -$2.4M | -$5.4M |
| Operating cash flow | -$8.5M | -$4.5M | -$5.2M | -$4.8M | -$3.4M |
| Free cash flow | -$8.9M | -$5.4M | -$6.2M | -$5.7M | -$4.1M |
| Diluted shares | 5.9M | 5.2M | 5.5M | 4.9M | 4.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $2.1M | $754.1K | $4.6M | $3.3M | $13.9M |
| Short-term investments | $39.1K | $187.9K | $202.1K | $233.0K | $313.3K |
| Total debt | $11.9M | $11.0M | $9.5M | $8.0M | $8.8M |
| Total assets | $51.4M | $48.6M | $51.5M | $50.5M | $55.0M |
| Total liabilities | $43.9M | $47.0M | $51.9M | $52.4M | $50.3M |
| Shareholders' equity | $6.3M | $1.5M | -$452.9K | -$1.8M | $4.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology